Untreated Adult Acute Myeloid Leukemia Completed Phase 1 Trials for Lenalidomide (DB00480)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01132586Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaTreatment